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Abstract
Background—Limited population-based data on prevalence of childhood vision impairment 
(VI) and hearing loss (HL), and their co-occurrence with autism spectrum disorder (ASD) exists.
Objective—To examine prevalence and characteristics of VI, HL and co-occurring ASD among 
8-year-olds in metropolitan Atlanta 2000–2008.
Methods—We used data from the population-based Metropolitan Atlanta Developmental 
Disabilities Surveillance Program. Prevalence, birth and parental characteristics, presence and 
severity of other co-occurring developmental disabilities, and age of earliest identification of 
ASD, were examined for children with VI and HL, by co-occurring ASD.
Results—VI and HL prevalences were 1.2 and 1.3 per 1000 8-year-olds, respectively. 
Approximately 6–7% of children with VI or HL had co-occurring ASD. Children with VI or HL 
with co-occurring ASD differed from those without co-occurring ASD by select birth 
characteristics and the presence of other co-occurring DDs. The median age of earliest known 
ASD diagnosis was significantly later among children with VI and ASD compared to children 
with ASD without VI (79 vs. 56 months). Children with HL and ASD were first evaluated by a 
community provider significantly earlier than those with ASD without HL (40 vs. 50 months).
Conclusions—The frequency of co-occurring ASD with VI and HL is higher than the 
population prevalence of ASD. The significant delays in diagnosis of ASD in children with VI and 
lack of earlier diagnosis of ASD among children with HL despite earlier evaluation highlight the 
importance of developing screening tools for early identification of ASD among children with VI 
and HL.
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Vision impairment (VI) and hearing loss (HL) are serious developmental disabilities (DDs) 
affecting children globally. Children with VI or HL are considered to be at risk for problems 
with emotional, behavioral, neurological, and physical development.1,2 They are also faced 
with lifelong challenges in daily functioning, social participation, and health outcomes, 
which may be exacerbated by the presence of co-occurring developmental disabilities 
(DDs).3–5 Autism spectrum disorder (ASD) has been described to co-occur with VI or HL 
due to neurological or other factors during birth or early childhood.6–12 While population-
based United States (US) data have reported the co-occurrence of DDs among children with 
VI or HL, particularly with cerebral palsy (CP) and intellectual disability (ID),13,14 
comparable results are limited on the co-occurrence of VI or HL, with ASD. Recent 
population-based prevalence estimates can provide empiric evidence to understand the 
resource and planning needs for children with VI or HL and co-occurring ASD as well as 
suggest areas for investigation of causes.
Current evidence on VI and ASD include a handful of studies outside the US, which 
employed different methodologies and report ranges of co-occurrence of VI and ASD from 
12 to 70% (Table 1). The 2009–2010 Annual Survey of Deaf and Hard of Hearing Children 
and Youth (ASDHHCY), reports the co-occurrence of ASD and mild to profound HL to be 
approximately 2%.17 Given the potential challenges in identifying behaviorally defined 
disorders among children with major sensory limitations, detailed examination of the 
prevalence, characteristics, and timing of identification of co-occurring ASD among 
children with VI or HL is necessary. Significant increases in ASD prevalence among 
children in various US communities further underscores the need to explore this issue.18,19 
Furthermore, early identification of ASD among children with VI and HL and appropriate 
intervention may improve long-term outcomes.20 Yet, little is known about the timing of 
identification of ASD among children with VI and HL.
Socio-demographic characteristics, and factors such as parental age at delivery, low birth 
weight, and preterm birth have been reported to be independently associated with VI21,22 as 
well as HL.14,22 Similarly, a literature review found various associations between the above 
factors and ASD.23 Nevertheless, these factors have not been examined related to the co-
occurrence between VI and ASD, or HL and ASD, and may suggest areas for exploration 
regarding potential shared risk factors or etiologies.
The Metropolitan Atlanta Developmental Disabilities Surveillance Program (MADDSP), is 
a long-standing and unique population-based surveillance program that monitors VI, HL and 
other DDs among a heterogenous population of 8-year-old children living in metropolitan 
Atlanta using objective, systematic measures for case ascertainment and definition.24 Data 
from the 2000–2008 MADDSP surveillance years were used to examine three study 
objectives among children with VI and HL overall, and by co-occurring ASD to: 1) estimate 
population period prevalence; 2) examine birth and parental characteristics, presence and 
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MADDSP uses a multiple source methodology for active population-based surveillance of 
five DDs including VI, HL, ASD, CP, and ID in five counties (Clayton, Cobb, DeKalb, 
Fulton, and Gwinnett) of metropolitan Atlanta, Georgia. Children are identified from record 
review at nine public school systems and selected private and public health sources that 
treat, diagnose, and/or serve children with DDs. Multiple records for a given child are 
compiled into one composite record which is then reviewed by a team of clinician reviewers 
to determine final case status. Additional methodological details have previously been 
published.24 This project was approved by the Institutional Review Board at the Centers for 
Disease Control and Prevention (CDC).
Study period
We used MADDSP data from five surveillance years: 2000, 2002, 2004, 2006, 2008, 
hereafter referred to as ‘2000–2008’.
Case definitions
A case is defined as a child aged 8 years at any time during the surveillance year of interest, 
whose parent or legal guardian(s) resided in the five-county metropolitan Atlanta during the 
respective surveillance year, and who meets criteria for one or more of five DDs.
Vision impairment
VI is defined as a measured visual acuity of 20/70 or worse in the better eye with correction. 
In the absence of a measured visual acuity, VI is defined based on a source record that 
includes a functional description, by a qualified physician or vision professional, of visual 
acuity of 20/70 or worse (e.g., light perception only) or a statement by a qualified physician 
or vision professional that the child had low vision or blindness. VI severity was defined as: 
a) ‘low vision’ with a visual acuity 20/70 to better than 20/200; b) ‘legal blindness’, with a 
visual acuity of 20/200 or worse, and c) cerebral visual impairment.
Hearing loss
HL is defined as a measured, bilateral, pure-tone hearing loss at frequencies of 500, 1,000, 
and 2000 Hz averaging ≥40 dB, unaided, in the better ear. Severity of HL was defined based 
on the measurement in the better ear: moderate (hearing loss of 40–64 dB), severe (hearing 
loss of 65–84 dB), and profound (hearing loss of ≥85 dB).25
Autism spectrum disorder
ASD is defined by the documentation of behaviors (as described on a comprehensive 
evaluation by a qualified professional) that are consistent with the diagnostic criteria listed 
in the Diagnostic and Statistical Manual-IV, Text Revision (DSM-IV-TR) for any of the 
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following conditions: Autistic Disorder, Pervasive Developmental Disorder-Not Otherwise 
Specified (PDD-NOS, including Atypical Autism), or Asperger Disorder.19,26
Intellectual disability
ID is defined as an intelligence quotient (IQ) of ≤70 on the most recently administered 
psychometric test. ID severity is defined based on the International Classification of 
Diseases, Ninth Edition, Clinical Modification27: mild (IQ = 50–70), moderate (IQ = 35–
49), severe (IQ = 20–34), and profound (IQ <20).
Cerebral palsy
CP is defined by documentation of a CP diagnosis or description of physical findings 
consistent with CP noted in clinical evaluation(s) at age 2 or older by a qualified 
professional.24,28 Children with CP acquired after birth (post-neonatal CP) are included. CP 
subtypes are categorized as spastic (monoplegia, hemiplegia, diplegia, quadriplegia, or 
triplegia), non-spastic (dyskinetic, ataxic, hypotonic, dyskinetic-ataxic) and mixed CP or CP 
NOS (spastic-ataxic, spastic-dyskinetic, spastic athetoid, mixed CP or CP NOS).
Epilepsy and Down syndrome
Information on epilepsy and Down syndrome were abstracted from MADDSP records, if 
documented in the record by a medical doctor, a psychologist, or an educator.
Congenital malformations
Information on congenital malformations, syndromes, and chromosomal abnormalities was 
obtained by linkage with the Metropolitan Atlanta Congenital Defects Program 
(MACDP),29 a population-based birth defects surveillance program of children born to 
mothers who resided within the five-county region of metropolitan Atlanta at the time of 
their birth. Diagnoses of congenital malformations were confirmed and classified by 
MACDP clinicians. MACDP is described elsewhere.30
Birth, parental, and demographic characteristics
Information on birth, maternal and paternal characteristics were obtained from linkage with 
birth certificate data of children born in metropolitan Atlanta. Birth certificate data were not 
obtainable for children born outside of the 5 county metropolitan Atlanta who migrated into 
metropolitan Atlanta between birth and age 8 years (35%). We conducted a sub-analysis on 
selected characteristics of children with VI or HL by whether they were non-migrants (born 
and residing in metropolitan Atlanta at age 8) or in-migrants (born outside of metropolitan 
Atlanta and moved in by age 8) (data not shown). We found no difference between non-
migrant and in-migrant children with HL by sex, severity of HL or presence of co-occurring 
DD. Differences were found between non-migrant and in-migrant children with VI by sex, 
race and ethnicity, and presence of co-occurring DDs, but not by severity of VI, which we 
believe may be the strongest indicator for selective migration. Child’s race/ethnicity was 
obtained primarily from abstracted MADDSP records and supplemented with information 
from the child’s birth certificate if not available from the abstracted data.
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The prevalence for VI and HL was estimated per 1000 8-year-olds residing in the 
metropolitan Atlanta area during surveillance years 2000–2008. Denominator data were 
obtained from the CDC National Center for Health Statistics postcensal 2009 vintage 
population estimates for 2000–2008 surveillance years yielding a total of 230,973 8-year-
olds in metropolitan Atlanta.31 Average annual period prevalence estimates, henceforth 
referred to as ‘prevalence’, were calculated for 2000–2008 overall by summation of the 
numerator data divided by the summation of denominator data across all surveillance years. 
The 95% confidence intervals (CIs) were calculated using the Poisson approximation to the 
binomial distribution. Poisson regression was used to test for linear trends in the VI and HL 
prevalence estimates from 2000 to 2008. Chi square or Fisher exact test of significance was 
used to examine differences in prevalence by sex and race/ethnicity as well as selected birth 
and parental characteristics, severity, co-occurring DDs between children with VI or HL 
with and without ASD.
Children were considered to have a previously documented ASD classification if they 
received a diagnosis of Autistic Disorder, PDD-NOS, Asperger Disorder, or ASD that was 
documented in an abstracted evaluation or by an ICD-9 billing code at any time from birth 
through the end of the year when they reached age 8 years, or if they received special 
education services under an autism eligibility. Ages at earliest known ASD diagnosis and 
earliest evaluation were calculated by subtracting the earliest date or age of known diagnosis 
or evaluation from the child’s date of birth. An earlier historical ASD diagnosis was taken if 
specified in a comprehensive evaluation. Between group differences in the median age of 
ASD evaluation were examined using the Mann–Whitney test. All statistical analyses were 
conducted using SAS (version 9.2; SAS Institute, Cary, NC).
Results
Vision impairment
The prevalence of VI during 2000–2008 was estimated as 1.2 per 1000 8-year-olds (95% CI 
= 1.1–1.4). Prevalence estimates across 2000–2008 were stable (p = 0.12) (data not shown). 
VI prevalence was higher among Hispanic children compared with White non-Hispanic 
children (p = 0.05), but did not differ significantly between boys and girls or between White 
and Black non-Hispanic children (Table 2). Sixty three percent of children with VI had at 
least another DD (including ASD, CP, ID, and/or HL). The frequency of ASD among 
children with VI was 7.2% (95% CI: 4.6–11.2); comprised of children with VI and ASD 
only (1.4%), and those with VI, ASD and other DDs (5.8%). These were lower than the co-
occurrence of VI and ID (52.5%) and VI and CP (41.0%), but the overall frequency was 
slightly higher than VI and HL overall (5.8%) (Table 3). Among other conditions examined, 
19.1% of children with VI had congenital malformations, Down syndrome, or a 
chromosomal abnormality, and 29.1% had epilepsy.
The prevalence of VI and co-occurring ASD was estimated as 0.09 per 1000 8-year-olds 
(95% CI = 0.06–0.13) and there was no significant linear trend in the prevalence estimates 
of this co-occurrence over the study period (p = 0.44). No significant differences were noted 
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in the prevalence of VI with ASD by sex and race/ethnicity (Table 2). Children with VI and 
ASD were significantly more likely to be low birth weight (p = 0.01) and/or a preterm birth 
(p = 0.02) (Table 4) and had a significantly higher frequency of co-occurring ID (p = 0.04), 
compared to children with VI without ASD (Table 3). Three out of 20 children with VI and 
ASD had a congenital malformation, syndrome, or chromosomal abnormality.
Approximately 70.0% of children with VI and ASD had a previously documented ASD 
classification compared to 81.5% of children with ASD without VI. There was no difference 
in the median age of earliest evaluation between children with VI and ASD compared with 
children with ASD without VI (Table 5). Yet, the median age of earliest known ASD 
diagnosis in children with VI was significantly later (79 months) compared with children 
with ASD without VI (56 months, p = 0.02).
Hearing loss
The prevalence of HL during 2000–2008 was estimated as 1.3 per 1000 8-year-olds (95% CI 
= 1.2–1.5). The annual HL prevalence estimates during the surveillance period did not vary 
significantly (p = 0.28) (data not shown). Overall, HL prevalence did not differ significantly 
by sex or race/ethnicity. Seventy seven percent of children with HL had co-occurring ASD, 
CP, ID or VI. The frequency of ASD among children with HL was 5.8% (95% CI = 3.7%–
9.3%); including those with HL and ASD only (1.6%) and HL, ASD and other DDs (4.2%). 
The frequency of other co-occurring DDs among children with HL was highest for ID 
(23.7%) followed by CP (10.7%) and VI (5.2%). One half of children with HL had moderate 
loss, 23.7% were in the severe range and 26.9% had profound HL (Table 3). Among the 
other medical conditions examined, 12.3% of children with HL had a major congenital 
malformations syndrome, or chromosomal abnormality, 7.5% had epilepsy, and 2.3% had 
Down syndrome.
The prevalence of HL co-occurring with ASD was estimated as 0.08 per 1000 8-year-olds 
(95% CI = 0.05–0.12), with no significant linear trend in the prevalence over the 
surveillance period (p = 0.60). The prevalence of HL with co-occurring ASD was 
significantly higher among boys compared to girls; however, this was based on small 
samples (Table 2). Children with HL and ASD had a significantly different sex distribution 
compared to children with HL without ASD (p = 0.01) (Table 3). The majority of children 
with HL and ASD had moderate HL (61.1%). A greater proportion of children with HL and 
co-occurring ASD had co-occurring ID and co-occurring CP compared to children with HL 
without ASD. No significant differences were found between children with HL with and 
without ASD according to the other birth and parental characteristics examined (Table 4).
The proportion of children with a previously documented ASD classification was similar for 
children with ASD and HL and those with ASD without HL (77.8% and 81.4%, 
respectively). Comparison of median ages of first evaluation showed that children with ASD 
and HL appeared to have been evaluated significantly earlier than those with ASD without 
HL (40 months vs. 50 months) (p = 0.01) (Table 5). Nevertheless, the median age of earliest 
known ASD diagnosis among children with HL (57 months) was similar to the age of ASD 
diagnosis in children with ASD without HL (56 months).
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This is the first US population-based report detailing the frequency, presence, and timing of 
community identification of co-occurring ASD among children with VI or HL. Early 
identification of ASD is particularly important among children with sensory disabilities, as 
these children may require different or additional interventional approaches or both, relative 
to children with ASD, but without VI or HL. Furthermore, disparities in the timing of 
evaluation and diagnosis of children with VI or HL and co-occurring ASD compared with 
their peers with ASD without these sensory conditions highlight the need to develop tools 
specific for identification of ASD within this population and a greater awareness within the 
clinical community.
While the frequencies of ASD among children with VI (7.2%) and HL (5.8%) were stable 
from 2000 to 2008, the prevalence of ASD increased significantly (83%) from 6.5 per 1000 
(95% CI = 5.8–7.3) in 2000 to 11.9 per 1000 (95% CI = 11.0–12.9) in 2008 in metropolitan 
Atlanta using postcensal denominator data.18,19,32 Despite the increase in overall ASD 
prevalence compared with the stability of VI and HL prevalence, ASD prevalence among 
children with VI and HL was consistently higher than the population prevalence of ASD 
among 8-year-olds.
Several causal pathways have been proposed that infer a greater risk of ASD among children 
with VI (e.g., retrolental fibroplasia, Leber’s congenital amaurosis, rubella) and a handful of 
case series reported co-occurrence with ASD or autism-like features in selected groups of 
children with VI.8,33–37 However these data on reported co-occurrence need to be 
interpreted with caution as individual study case definitions and methods vary. Four 
studies9,10,15,16 examined co-occurrence of VI and ASD, where ASD diagnosis was based 
on either DSM IVor International Classification of Diseases (ICD) 10 criteria (Table 1). One 
of these studies examined the frequency of autism among children and adolescents attending 
schools for the visually impaired defining VI through clinical examination by an 
ophthalmologist and found that 12% (n = 30/ 257) of children with VI also had ASD.15 
Their estimate is comparable to the upper bound of our rate of VI and ASD co-occurrence 
(7.2%; 95% CI = 4.6%–11.2%).
While the median age of first evaluation for children with VI and ASD was similar to those 
with ASD without VI, it was concerning that the age of earliest known ASD diagnosis was 
much later for children with VI and ASD in our study. Current diagnostic instruments used 
to detect ASD by assessing eye contact, joint attention, and gesture have not been validated 
in children with VI.38 Also, several items in the evaluation of children for ASD rely on 
vision, social interaction, and intelligence testing, which likely cannot be applied to children 
with VI.39 Lack of feedback on social behavior and play experiences, limited interaction 
with others, and potential co-occurrence with other DDs, complicate assessment of ASD 
among children with VI.40 The Autism Diagnostic Interview is the only comprehensive 
instrument reported to identify ASD in children with VI, but further work is needed.41
The co-occurrence between HL and ASD was first suggested in the 1970s,42 and it was 
believed that HL was a possible cause for autism,43 pointing to social isolation, emotional 
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distress, psychological disorders, and language deficits in children with HL as potential 
pathways to a subsequent diagnosis of autism.18,44 Conditions such as cytomegalovirus, 
toxoplasmosis, bacterial meningitis, rubella and measles have also been proposed as possible 
risk factors for co-occurrence of HL and ASD.11 Two previous studies found varying rates 
of ASD among children with HL (2–5%).11,17 Most comparable to MADDSP, the 2009–
2010 ASDHHCY reported that 1 in 59 (1.7%; 95% CI = 1.8%–2.1%) children in the US 
with HL had ASD based on clinical ASD diagnosis or autism special education placement 
documented in education records.17 This estimate is lower than our finding (5.8%; 95% CI = 
3.7%–9.3%). Given that approximately 22% of children with HL and ASD in MADDSP did 
not have a previously documented ASD classification by a community provider, the 
significantly lower estimate reported by the Annual Survey may be attributable to under-
identification of ASD among children with HL in the community. Of note, the ASDHHSY 
reported that the majority of children with ASD had profound HL while we found that the 
majority of children with HL and ASD functioned in the moderate range.
Previous studies have shown that communication limitations delay the timing of ASD 
diagnosis in children with HL.11,45 Interestingly, in the current study, the median age at first 
evaluation for children with HL and ASD was earlier than for children with ASD and no 
HL, yet the median age of earliest known ASD diagnosis was the same regardless of the 
presence of co-occurring HL. Diagnostic overshadowing indicated by the masking of a 
diagnosis of ASD in children with HL and ID, discussed by Szymanski et al (2012), may be 
occurring in our study for HL as well as VI.17 The earlier age of evaluation among children 
with HL is encouraging and indicates an opportunity for earlier identification of ASD, but 
underscores the need for improved diagnostic tools and education for potentially confirming 
a possible co-occurring diagnosis of ASD with the goal of facilitating earlier receipt of 
appropriate services.
With respect to birth characteristics as shared risk factors, low birth weight and preterm birth 
are suggested to expose the developing visual systems in the fetus to high levels of oxygen 
and early light stimulus, resulting in sub-optimal vision development.21,22,46,47 Disruption in 
typical neuronal development has been suggested as a common pathway for VI, HL, and 
ASD among children born preterm.9 Schendel and Bhasin (2008), using data from 
MADDSP, showed an increased prevalence of VI and HL, as well as ASD, among children 
born preterm compared to term.22 Sex, plurality, maternal age, race/ethnicity, and parental 
education have all been considered to play a role in the etiology and association between 
low birth weight, gestational age, and VI, HL, and ASD as individual conditions,22 but there 
have been no population-based data on the influence of these factors on the co-occurrence of 
VI or HL and ASD. HL and VI are low prevalence conditions and as a result the sample 
sizes for children with VI or HL and co-occurring ASD are somewhat limited when 
stratified by various socio-demographic and birth characteristics. Nevertheless, MADDSP 
data are uniquely capable of examining these issues. Interestingly, the only differences we 
found in the presence of co-occurring ASD was for children with VI by birth weight and 
gestational age. As MADDSP continues to accumulate additional surveillance data, we plan 
to revisit these findings.
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Our study also contributes recent overall, sex, and racial/ethnic specific prevalence estimates 
of childhood VI and HL. The 2000–2008 MADDSP prevalence estimates for VI and HL 
were comparable to those reported for previous surveillance years using the MADDSP 
methods.4,48,49 While our VI prevalence (1.2 per 1000) was comparable to the reported 
prevalence of “blindness/ unable to see at all” based on parental report from the 1997–2008 
National Health Interview Survey (1.3 per 1000 children aged 3–17 years), the reported 
prevalence of “moderate to profound hearing loss” based on parental report (4.5 per 1000) 
was much higher than that found in MADDSP (1.3 per 1000).4,32 The discordance between 
HL prevalence estimates may be attributable to a more liberal definition of HL being 
interpreted upon parental report compared to the objective, audiologic test scores and 
established cut-offs used to define moderate to profound HL in MADDSP.
The strengths of MADDSP include systematic and consistent methodology, a 
comprehensive approach to case ascertainment, and rigorous quality assurance. MADDSP 
uses objective test data to determine case status for VI and HL rather than a more subjective 
measure such as parental report. In addition, MADDSP does not rely solely on a clinical 
diagnosis of autism or special education autism classification, but rather on documented 
behaviors consistent with ASD. Therefore, MADDSP identifies children who were not 
previously identified with ASD by a community professional, a group likely not identified 
as having ASD by other studies.
Our results are subject to a few limitations. Retrospective review of administrative records 
for case ascertainment relies on the availability and quality of information documented in 
the source records. If limited, this may result in under-identification of behaviors and 
diagnoses of ASD among children with VI and HL. Given functional limitations related to 
the child’s VI or HL, evaluation and diagnosis of ASD in children with VI and HL may be 
challenging and result in an underestimation of the number of children with VI and ASD or 
HL and ASD. We speculate that the proportion of children with VI or HL with a co-
occurring congenital malformations, syndromes, or abnormalities other than Down 
syndrome may also be an underestimate as MADDSP does not actively collect this 
information on children with DDs.
Conclusions
In summary, our findings demonstrate that the frequency of co-occurring ASD among 
children with VI or HL has been stable over time, but consistently higher than ASD 
prevalence among 8-yr-olds in metropolitan Atlanta for 2000–2008. The delay found in the 
age of diagnosis for children with VI, and lack of earlier ASD diagnosis despite earlier 
evaluation among children with HL, underscore the need for development of valid and 
reliable diagnostic tools coupled with greater awareness of behaviors consistent with ASD 
among clinicians serving children with VI and HL. Improved tools and greater awareness 
are needed to provide more complete and timely identification of ASD among children with 
VI or HL and greater subsequent planning of educational, interventional, and preventative 
services for affected children. Our findings also suggest potential venues for future 
investigation of shared risk factors for the co-occurrence of VI or HL with ASD. As such, 
Kancherla et al. Page 9













focused efforts are needed to better understand preventable risk factors and causes of ASD 
in children with VI or HL, to ultimately improve the quality of life of those affected.
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Table 5
Median age at first evaluation and/or diagnosis of autism spectrum disorder by co-occurring vision impairment 
or hearing loss, Metropolitan Atlanta Developmental Disabilities Surveillance Program, 2000–2008
Median age at earliest evaluation
N Median (months)
ASD with VI 20 46
ASD without VI 2078 50
TOTAL ASD 2098 Median difference
 p value = 0.37
ASD with HL 18 40
ASD without HL 2080 50
TOTAL ASD 2098 Median difference
 p value = 0.02a
Median age at earliest known ASD diagnosis
N Median (months)
ASD with VI 12 79
ASD without VI 1233 56
TOTAL ASD 1245 Median difference
 p value = 0.02a
ASD with HL 11 57
ASD without HL 1234 56
TOTAL ASD 1245 Median difference
 p value = 0.83
ASD = autism spectrum disorder; HL = hearing loss; MADDSP = Metropolitan Atlanta Developmental Disabilities Surveillance Program; SD = 
standard deviation; VI = vision impairment.
a
p value significant at <0.05.
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